’ meeting on the said date in which the meeting had resolved to call for an Annual General Meeting of Shareholders for 2024. Even so, NUSA has yet to inform the SEC on the change of the 3 new directors in
Laboratories Co., Ltd. is a listed company established in the year 1971. The manufacture and distribution of conventional medicine. Office and Factory are located at No.47 Soi Boonchana, Sukhumvit 59, Klong Ton
security patients which generated high margin and effect of increase of social security payment rate in 1H’18. Moreover, the efficient cost management such as medicine & medical supplies as well as the
established in 2011 and operated business Original Equipment Manufacturer or OEM for skincare, cosmetics, supplementary food and skin medicine under trademarks including trademark of “DERMALIS”, (which will be
) Loan payment, which At-Ze borrowed from the Company to pay the director back money it owes to the director as Seller’s connected person in the amount of THB 125 million at the share sale and purchase
rehabilitation services for patients with diabetes. Kasemrad International Hospital Rattanathibeth opened an Advanced Internal Medicine on the 2nd floor with a team of doctors and personnel who are specialized in
mobile check-up cost, nurses and medical staff salary, medicine cost. The company’s gross profit in Q2/2017 was THB 34.82 million, slightly decreased from THB 35.06 in Q2/2016. The company’s net income in
such as mobile check-up cost, nurses and medical staff salary, medicine cost. The company’s gross profit in Q2/2017 was THB 34.82 million, slightly decreased from THB 35.06 in Q2/2016. Profit
attendance to join the meeting and vote at the Extraordinary General Meeting of Shareholders No. 1/2020. 3. Approval of significant changes in the objectives of using IPO funds in the event that there is a
the Company; (7) The Company has duly appointed one person nominated by PLANB as a director of the Company; (8) The Company shall have procured that Clause 3.2 (Renewal) of the Agreement in respect of